Amphetamines in the management of children's hyperkinesis.
D000662:Amphetamines / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002648:Child; D003913:Dextroamphetamine / Q000627:therapeutic use; D004032:Diet; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use; D010389:Pemoline / Q000627:therapeutic use
D000662:Amphetamines; D000929:Antidepressive Agents, Tricyclic; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D010389:Pemoline; D003913:Dextroamphetamine